Major histocompatibility complex class II-CD4+ T-cell receptor complex (MHC II-TCR complex)

The Major Histocompatibility Complex (MHC) class II-CD4+ T-cell receptor (TCR) complex is a fundamental molecular assembly of the adaptive immune system, responsible for the recognition of exogenous antigens. This complex forms when an antigen-presenting cell (APC) displays a peptide fragment—often derived from a carrier protein such as CRM197 or Tetanus Toxoid in conjugate vaccines—within the MHC class II molecule to a cognate TCR on a CD4+ helper T cell (Avci et al., 2011, Nature Medicine). The interaction is stabilized by the CD4 co-receptor and is essential for initiating T-cell help, which involves cytokine secretion and signaling to B cells for high-affinity antibody production and isotype switching (Janeway et al., 2001, Immunobiology). In the context of vaccinology, this complex is the primary target for conjugate vaccines designed to elicit long-term immunological memory against polysaccharide-encapsulated bacteria (Pollard et al., 2009, Nature Reviews Immunology). Furthermore, the MHC II-TCR interaction is a key therapeutic target in autoimmune diseases, where drugs like Abatacept modulate the synapse by interfering with necessary co-stimulatory signals (Moreland et al., 2006, NEJM).

Other names

MHC class II-CD4+ T-cell receptor complex recognizing carrier-protein-derived peptidesMHC II-peptide-TCR complexHLA-DR-TCR complexCD4-MHC II-TCR complexCarrier-peptide-MHC-TCR complex

The complex facilitates the presentation of carrier-protein-derived peptides by MHC class II molecules to CD4+ T-cell receptors, inducing T-cell help for B-cell antibody production and memory formation.